Myocardial perfusion scintigraphy (MPS) is a well-established non-invasive method for the evaluation of patients with suspected ischemic heart disease or with coronary artery disease (CAD). Its major diagnostic indication is in the assessment of patients with intermediate likelihood of CAD, with the diagnostic value being difficult to be dissociated from the prognostic information obtained with the method. Through several criteria validated in the literature, such as the extent of ischemia, the patient’s risk of presenting cardiovascular events in the future […]